St. Jude Medical CEO says devices for atrial fibrillation to boost growth

02/6/2011 | Reuters

St. Jude Medical CEO Daniel Starks said he believes the company will continue to experience sales growth, driven by new pacemakers and other cardiac-rhythm management devices that are designed to treat atrial fibrillation. The company said it has sufficient cash to buy back shares and acquire companies.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD